Ignite Creation Date:
2025-12-24 @ 10:15 PM
Ignite Modification Date:
2026-01-02 @ 12:33 AM
Study NCT ID:
NCT00423735
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2007-01-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2011-03-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-04
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-16
First Submit QC Date:
None
Study First Post Date:
2007-01-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-06-19
Results First Submit QC Date:
None
Results First Post Date:
2015-01-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-22
Last Update Post Date:
2019-07-24
Last Update Post Date Type:
ACTUAL